Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07249554 · ClinicalTrials.gov registry record · Phase 2
Combination Therapy for Alcohol Use Disorder
A Phase 2 study, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT07249554: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT07249554 is a Phase 2 study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07249554, a Phase 2 study, has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.
Interventions
- DRUG Placebo
- DRUG Naltrexone (oral tablets)
- DRUG Glucagon-Like Peptide-1 Agonist (GLP-1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07249554
The ClinicalTrials.gov registry entry for NCT07249554 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07249554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07249554 about?
NCT07249554 is a clinical study titled "Combination Therapy for Alcohol Use Disorder". This human laboratory study will collect preliminary safety and efficacy data from a sample of participants enrolled in a 4-week in-patient treatment program for alcohol use disorder.
What is the current status of trial NCT07249554?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2026-07. Estimated completion is 2028-09.
What interventions are being tested in trial NCT07249554?
The interventions under investigation include: Placebo (DRUG), Naltrexone (oral tablets) (DRUG), Glucagon-Like Peptide-1 Agonist (GLP-1) (DRUG).
Who is sponsoring clinical trial NCT07249554?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.